Deutsche Bank
http://www.db.com/
Deutsche Bank is a leading global investment bank with a strong and profitable private clients franchise.
The company operates through three divisions: Corporate and Investment Bank (CIB), Private Clients and Asset Management (PCAM) and Corporate Investments (CI) . The CIB division engages in the origination, sale, financing, structuring, and trading of fixed income, equity, equity-linked, convertible bond, foreign exchange, and commodities products. The PCAM segment provides portfolio/fund management products, including active fund management, passive/quantitative fund management, alternative investments, and discretionary portfolio management solutions in Germany and other continental European countries.-
David Moenning’s Daily State of the Markets: 7/22
-
David Moenning's Daily State of the Markets: 7/10
-
David Moenning’s Daily State of the Markets: 6/26
-
Notable Analyst Rating Changes 4/22: F, CAT, BRCD, FDX Upgraded; NBR, CCO, HAL, WFR, FITB Downgraded
-
Morning Movers 3/12: CV Therapeutics (CVTX) Surges On Buyout, GE (GE) Up On Rating Cut/Stable Outlook
-
David Moenning's Daily State of the Markets: 12/16
-
Notable Analyst Rating Changes 11/12: BBBY, PAG, ROK Upgraded; EGLE, FMCN, BRCM Downgraded
-
Notable Analyst Rating Changes 9/12: WM, GILD, LCC, PBG Upgraded; BBY, BWLD, DHR Downgraded
-
Gilead (GILD) Lower On Fears of Flat HIV Growth Cited in BofA Downgrade, Another Analyst Takes Opposing View
-
David Moenning's Daily State of the Markets: 9/2
-
Deutsche Bank Starts Gilead (GILD) at Buy, Citing Strength in HIV Franchise
-
Deutsche Bank Starts Coverage on Large Biotechs; DNA, GILD & AMGN Rated Buys, BIIB & GENZ Rated Holds
-
David Moenning's Daily State of the Markets: 4/17
-
David Moenning's Daily State of the Markets: 2/22
-
David Moenning's Daily State of the Markets: 1/30
-
David Moenning's Daily State of the Markets:
-
Notable Analyst Rating Changes 1/15: STO, NOC, BIIB Upgraded; BP, SLB, GRMN, HAR Downgraded
-
David Moenning's Daily State of the Markets: 01/07
